Literature DB >> 18782898

Patient outcome after traumatic brain injury in high-, middle- and low-income countries: analysis of data on 8927 patients in 46 countries.

Mary J De Silva1, Ian Roberts, Pablo Perel, Phil Edwards, Michael G Kenward, Janice Fernandes, Haleema Shakur, Vikram Patel.   

Abstract

BACKGROUND: Traumatic brain injury (TBI) is one of the leading causes of death and disability worldwide. The burden of TBI is greatest in low- and middle-income countries (LAMIC), yet little is known about patient outcomes in these settings.
METHODS: Complete data on 8927 patients from 46 countries from the corticosteroid randomization after significant head injury (CRASH) trial were analysed to explore whether outcomes 6 months after TBI differed between high-income countries and LAMIC.
RESULTS: Just under half of patients experienced a good recovery, one-third moderate or severe disability and one-quarter died within 6 months of their injury. Univariate analyses showed that patients in LAMIC were more likely to die following severe TBI, but were less likely to be disabled following mild and moderate TBI. These results were confirmed in multivariate analyses. Compared to patients in high-income countries, patients in LAMIC have over twice the odds of dying following severe TBI (OR 2.23, 95% CI 1.51-3.30) but half the odds of disability following mild (OR 0.41, 95% CI 0.23-0.72) and moderate TBI (OR 0.53, 95% CI 0.35-0.81). There were no differences between settings in the odds of death following either mild or moderate TBI.
CONCLUSIONS: Reduced death rates following severe TBI in patients from high-income countries may be due to differences in medical care which may result in a higher proportion of patients surviving with a disability. Socio-cultural factors may explain the lower levels of disability after mild and moderate TBI in LAMIC.

Entities:  

Mesh:

Year:  2008        PMID: 18782898     DOI: 10.1093/ije/dyn189

Source DB:  PubMed          Journal:  Int J Epidemiol        ISSN: 0300-5771            Impact factor:   7.196


  74 in total

Review 1.  Local and global challenges in pediatric traumatic brain injury outcome and rehabilitation assessment.

Authors:  L E Schrieff-Elson; N Steenkamp; M I Hendricks; K G F Thomas; U K Rohlwink
Journal:  Childs Nerv Syst       Date:  2017-09-06       Impact factor: 1.475

2.  Development of a Severe Traumatic Brain Injury Consensus-Based Treatment Protocol Conference in Latin America.

Authors:  Peter Hendrickson; James Pridgeon; Nancy R Temkin; Walter Videtta; Gustavo Petroni; Silvia Lujan; Nahuel Guadagnoli; Zulma Urbina; Perla Blanca Pahnke; Daniel Godoy; Gustavo Pinero; Freddy Sandi Lora; Sergio Aguilera; Andres M Rubiano; Caridad Soler Morejon; Manuel Jibaja; Hubiel Lopez; Ricardo Romero; Sureyya Dikmen; Kelley Chaddock; Randall M Chesnut
Journal:  World Neurosurg       Date:  2017-12-05       Impact factor: 2.104

3.  The Outcome of Severe Traumatic Brain Injury in Latin America.

Authors:  Robert H Bonow; Jason Barber; Nancy R Temkin; Walter Videtta; Carlos Rondina; Gustavo Petroni; Silvia Lujan; Victor Alanis; Gustavo La Fuente; Arturo Lavadenz; Roberto Merida; Manuel Jibaja; Luis Gonzáles; Antonio Falcao; Ricardo Romero; Sureyya Dikmen; James Pridgeon; Randall M Chesnut
Journal:  World Neurosurg       Date:  2017-12-09       Impact factor: 2.104

4.  Mortality-Associated Characteristics of Patients with Traumatic Brain Injury at the University Teaching Hospital of Kigali, Rwanda.

Authors:  Elizabeth Krebs; Charles J Gerardo; Lawrence P Park; Joao Ricardo Nickenig Vissoci; Jean Claude Byiringiro; Fidele Byiringiro; Stephen Rulisa; Nathan M Thielman; Catherine A Staton
Journal:  World Neurosurg       Date:  2017-03-21       Impact factor: 2.104

Review 5.  Collective Review of the Status of Rapid Sequence Intubation Drugs of Choice in Trauma in Low- and Middle-Income Settings (Prehospital, Emergency Department and Operating Room Setting).

Authors:  Leressè Pillay; Timothy Hardcastle
Journal:  World J Surg       Date:  2017-05       Impact factor: 3.352

Review 6.  Pediatric Trauma Care in Low- and Middle-Income Countries: A Brief Review of the Current State and Recommendations for Management and a Way Forward.

Authors:  Andrew W Kiragu; Stephen J Dunlop; Benjamin W Wachira; Seno I Saruni; Michael Mwachiro; Tina Slusher
Journal:  J Pediatr Intensive Care       Date:  2016-06-24

7.  Severe Traumatic Brain Injury at a Tertiary Referral Center in Tanzania: Epidemiology and Adherence to Brain Trauma Foundation Guidelines.

Authors:  Luke R Smart; Halinder S Mangat; Benson Issarow; Paul McClelland; Gerald Mayaya; Emmanuel Kanumba; Linda M Gerber; Xian Wu; Robert N Peck; Isidore Ngayomela; Malik Fakhar; Philip E Stieg; Roger Härtl
Journal:  World Neurosurg       Date:  2017-05-27       Impact factor: 2.104

8.  Treadmill exercise protects against pentylenetetrazol-induced seizures and oxidative stress after traumatic brain injury.

Authors:  Luiz Fernando Almeida Silva; Maurício Scopel Hoffmann; Rogério da Rosa Gerbatin; Fernando da Silva Fiorin; Fernando Dobrachinski; Bibiana Castagna Mota; Angelica Terezinha Barth Wouters; Saulo Petinatti Pavarini; Félix Alexandre Antunes Soares; Michele Rechia Fighera; Luiz Fernando Freire Royes
Journal:  J Neurotrauma       Date:  2013-07-15       Impact factor: 5.269

9.  Survival and Functional Outcomes at Discharge After Traumatic Brain Injury in Children versus Adults in Resource-Poor Setting.

Authors:  Laura N Purcell; Rachel Reiss; Jessica Eaton; Ken-Kellar Kumwenda; Carolyn Quinsey; Anthony Charles
Journal:  World Neurosurg       Date:  2020-02-19       Impact factor: 2.104

10.  An evaluation of outcomes in patients with traumatic brain injury at a referral hospital in Tanzania: evidence from a survival analysis.

Authors:  Cyrus Elahi; Thiago Augusto Hernandes Rocha; Núbia Cristina da Silva; Francis M Sakita; Ansbert Sweetbert Ndebea; Anthony Fuller; Michael M Haglund; Blandina T Mmbaga; João Ricardo Nickenig Vissoci; Catherine A Staton
Journal:  Neurosurg Focus       Date:  2019-11-01       Impact factor: 4.047

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.